SELLAS Life Sciences Group Announces $23.6 Million Warrant Inducement Transaction

Sullivan & Worcester has advised A.G.P./Alliance Global Partners and Maxim Group LLC.SELLAS Life Sciences Group, Inc. (NASDAQ: SLS), a late-stage clinical biopharmaceutical company, has announced the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here